The MarketWatch News Department was not involved in the creation of this content. Vail, Colorado, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has secured a $100,000 ...
Vail, Colorado, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has secured a $100,000 gift from longtime supporter Bjorn Erik Borgen to sustain a critical training and ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
The International Olympic Committee said on Wednesday it would announce eligibility criteria for transgender athletes early next year, after months of deliberation as it seeks to find a consensus on ...
7th January 2026: We updated our list of working The Forge codes. The Forge is a Roblox tycoon RPG about running a forge. In The Forge, you’ll mine to earn minerals and then forge them into cool ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
According to multiple reports, the International Olympic Committee (IOC) is moving toward implementing a ban on transgender athletes in the Olympic Games. The IOC responded to the reports, stating ...
IOC and Saudi Arabia end Esports partnership early Had agreed 12-year deal in 2024 Riyadh had been due to host 2027 Esports Olympics BERLIN, Oct 30 (Reuters) - The International Olympic Committee and ...
SEOUL, KOREA - FEBRUARY 1: A general view of the Official Olympic Flag taken during the 1988 Olympic Games in Seoul, Korea. (Photo by: Getty Images/Getty Images North America) Photo Illustration Getty ...
Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback